Alkem Laboratories’ Bioequivalence Center clears US FDA inspection without observations

Share it

Shares of Alkem Laboratories Ltd ended at ₹4,686.80, down by ₹63.55, or 1.34%, on the BSE.

Leave a Comment

Your email address will not be published. Required fields are marked *